EP Patent

EP3473253A1 — Methods of treating age-related symptoms in mammals and compositions therefor

Assigned to University of Maryland Baltimore · Expires 2019-04-24 · 7y expired

What this patent protects

A method of alleviating age-related symptoms in a mammal, which comprises a step of administering to a mammal in need thereof, an effective amount of a composition containing an effective amount of at least methylene blue.

USPTO Abstract

A method of alleviating age-related symptoms in a mammal, which comprises a step of administering to a mammal in need thereof, an effective amount of a composition containing an effective amount of at least methylene blue.

Drugs covered by this patent

elamipretide-hydrochloride (ELAMIPRETIDE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3473253A1
Jurisdiction: EP
Classification: —
Expires: 2019-04-24
Drug substance claim: No
Drug product claim: No
Assignee: University of Maryland Baltimore
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.